S-Case, a Slovak medical technology firm, has secured an investment round of EUR 500,000 from new investors to enhance its remote patient monitoring solution, Scase, in response to the increasing demand for telemedicine.

Target Information

Slovak medical technology company S-Case has recently welcomed new investors Y Soft Ventures, AI Startup Incubator, and Vít Horký, former CEO of Brand Embassy. This strategic investment round, initiated in early 2022, aims to bolster S-Case’s market entry both domestically and internationally, while facilitating the final enhancements of its medical solution, Scase, which specializes in remote patient monitoring. The ongoing investment round has accumulated a total of EUR 500,000.

Industry Overview in Slovakia

Over the past two years, the significance of telemedicine has surged, particularly following the onset of the Covid-19 pandemic. A survey conducted by Kaspersky revealed that 44% of participants have begun utilizing telemedicine as a result of the pandemic. Furthermore, an overwhelming 56% of medical facilities plan to increase their telemedicine investments, reflecting the sector's rapid evolution.

Moreover, 71% of healthcare providers believe that telemedicine will be pivotal in adding value to health systems over the next five years. This g